ANORECTAL VARICES, HAEMORRHOIDS, AND PORTAL HYPERTENSION

doi:10.1016/S0140-6736(89)91724-8

The Lancet

Volume 333, Issue 8634, 18 February 1989, Pages 349-352

https://doi.org/10.1016/S0140-6736(89)91724-8 Get rights and content

Abstract

In a prospective study of 100 consecutive patients with cirrhosis, 44% had anorectal varices. The prevalence of anorectal varices rose with progression of portal hypertension; it was 19% in cirrhotic patients without portal hypertension compared with 59% in those who had bled from oesophageal varices. There was no evidence that endoscopic sclerotherapy directly increased the prevalence of anorectal varices. Haemorrhoids occurred independently of anorectal varices and their presence was unrelated to the degree of portal hypertension. These data provide further evidence that haemorrhoids and anorectal varices are separate and distinct entities. However, both can bleed and careful examination is essential to prevent misdiagnosis and inappropriate treatment.

References (16)

GT. Watts
Piles are caused by varicose veins in the anal canal
Lancet
(1986)
D. Burman
Piles and portal hypertension
Lancet
(1986)
L. Witzel et al.
Prophylactic endoscopic sclerotherapy of oesophageal varices
Lancet
(1985)
An Hamlyn et al.
Portal hypertension with varices in unusual sites
Lancet
(1974)
E. Weinshel et al.
Hemorrhoids or rectal varices: defining the cause of massive rectal hemorrhage in patients with portal hypertension
Gastroenterology
(1986)
Whf. Thompson
The nature of haemorrhoids
Br J Surg
(1975)
JC. Goligher
Surgery of the anus rectum and colon
(1985)

There are more references available in the full text version of this article.

Cited by (191)

Gastrointestinal health and therapeutic carbohydrate restriction
2023, Ketogenic: The Science of Therapeutic Carbohydrate Restriction in Human Health
Human health is tied to the microbiome, and dysbiosis begets disease. Many gastrointestinal (GI) conditions cause unnecessary proliferation of normal gut microbiota, leading to dysbiosis, painful symptoms and hunger signal dysregulation. Dysbiosis causes damage to tight junctions and provides an entryway for pathogens to systemic circulation, which leads to a variety of conditions, including allergies, intolerances and even autoimmune reactions. Other disorders exist in the liver, pancreas, hepatic portal system and gallbladder, all of which follow from poor dietary choices. Therapeutic carbohydrate restriction or the ketogenic diet (KD) is, by nature, closely related to diets with evidence of efficacy for various GI conditions (namely, specific carbohydrate diet and low-FODMAP diets). Unsurprisingly then, evidence is emerging regarding a similar efficacy. The KD is animal-based and as such excludes many plant-based gut irritants. Some troubleshooting and individualisation may be required, but an adapted KD has long-term clinical potential to alleviate many GI conditions and deserves more clinical application.
Lower Gastrointestinal Bleeding
2019, Clinical Gastrointestinal Endoscopy
Acute severe lower gastrointestinal (GI) bleeding is a common problem and frequent reason for hospitalization with associated morbidity and mortality. Colonoscopy is often performed for diagnosis and potential therapeutic intervention. However, the optimal timing of colonoscopy remains unclear at this time. Common etiologies of lower GI bleeding include diverticulosis, postpolypectomy bleeding, arteriovenous malformation, colitis, malignancy, and radiation proctitis. Endoscopy therapy for lower GI bleeding is usually successful through a combination of hemoclips, injection of epinephrine, or ablation and coagulation. In cases of endoscopic failure, angiography and embolization are alternate therapeutic options. Surgery to control bleeding is rarely required.
The epidemiology and pathogenesis of gastrointestinal varices
2017, Techniques in Gastrointestinal Endoscopy
Gastrointestinal varices are a consequence of portal hypertension that can occur in the setting of cirrhosis or extrahepatic portal vein obstruction. Increased intrahepatic vascular resistance, a hyperdynamic circulation, and increased flow through the portal and collateral venous system lead to persistently elevated portal pressures that result in angiogenesis and formation of collaterals between the portal and systemic circulation. Despite this physiological attempt at decompression, portal hypertension persists as collateral vessels have higher resistance than the normal liver. Variceal wall tension is the main factor that determines vessel rupture and bleeding occurs when tension in the wall exceeds the limit of elasticity of the vessel. Progressive distension leads to increasing resistance to flow and hemorrhage ensues when the limits of resistance to further dilation are surpassed. Gastroesophageal varices are present in 50% of patients with cirrhosis and progress in size at a rate of 8%-10% per year. Hemorrhage occurs at a rate of approximately 12% per year and large esophageal varices carry a higher risk of rupture. Gastric varices occur in 20% of patients with portal hypertension and bleed less frequently, but more severely. Cardiofundal varices have a complex vascular anatomy that is important to consider as it pertains to the effectiveness of strategies used for management. Ectopic varices make up 2%-5% of all variceal bleeding, occur more frequently in patients with extrahepatic portal hypertension, and their identification should prompt assessment of the intra-abdominal vasculature. Varices in the setting of splenic vein thrombosis should be considered a distinct entity owing to their disparate etiologic basis and treatment approach.
Inflammatory bowel and oxidative stress changes in an experimental model of portal hypertension: Action of N-acetylcysteine
2016, Journal of Coloproctology
Citation Excerpt :
These conditions are known as Portal Hypertension Gastropathy (PHG) and Portal Hypertensive Colopathy (PHC), respectively, and the first of these conditions is already well established in the literature.3 Intestinal changes present in PH are still being elucidated and were gradually identified over the last decade as being mainly one of the causes of fatal gastrointestinal bleeding in patients with PH.4 The pattern of lesions in cases of PH can be found in other parts of the gastrointestinal tract, including the intestine,5 due to mucosal edema, inflammatory diseases, and ectopic and anorectal varices.6 The experimental model of Partial Portal Vein Ligation (PPVL) has been used by many authors to study the molecular changes in pre-hepatic portal hypertension.7–9
Portal hypertension (PH) is characterized by vasodilatation in the portal system and the bowel is one of the severely affected organs. N-acetylcysteine (NAC) is a molecule with important properties and widely used in clinical practice.
To evaluate NAC action in the bowel of animals submitted to the animal model of partial portal vein ligation (PPVL).
18 male Wistar rats were divided into three experimental groups (n = 6): sham-operated (SO), PPVL, and PPVL + NAC. On the 8th day after surgery, N-acetylcysteine (10 mg/kg, ip) was administered daily for 7 days. On the 15th day the animals’ bowel was collected for oxidative stress analysis, immunohistochemistry and Western blot. We evaluated the expression of NF-KB and TNF-α by immunohistochemistry and of iNOS by Western blot. Lipid peroxidation was assessed by TBARS technique, and the activities of antioxidant enzymes superoxide dismutase (SOD) and glutation peroxidase (GPx) were checked.
We observed an increased expression of NF-KB and TNF-α in PPVL group, and an increased iNOS expression assessed by Western blot. NAC reduced the expression of all proteins evaluated. We also observed an increase in oxidative stress in the bowel of mice PPVL group compared to controls (SO), and NAC was effective in reducing these values in PPVL + NAC group. Also, a reduction in the activity of SOD and GPx enzymes was observed in the diseased group, and NAC was able to restore the activity of the enzymes assessed.
We suggest the anti-inflammatory and antioxidant action of NAC in the bowel of animals submitted to PPVL model.
A Hipertensão Portal (HP) é caracterizada por uma vasodilatação no sistema portal, e o intestino é um dos órgãos gravemente acometidos. A N-acetilcisteína (NAC) é uma molécula com importantes propriedades, amplamente utilizada na clínica.
Avaliar a ação da NAC no intestino de animais submetidos ao modelo animal de ligadura parcial da veia porta (LPVP).
Foram utilizados 18 ratos machos Wistar divididos em três grupos experimentais (n = 6): Sham-operated (SO), LPVP, LPVP + NAC. No 8° dia após a cirurgia, a N-acetilcisteína (10 mg/kg,ip) foi administrada diariamente durante 7 dias. No 15° dia foi coletado o intestino dos animais para análises de estresse oxidativo, imunohistoquímica e Western blot. Nós avaliamos a expressão do NF-kb e TNF-α por imunohistoquímica e da iNOS por Western blot. A lipoperoxidação foi avaliada pela técnica de TBARS, e as atividades das enzimas antioxidantes Superóxido Dismutase (SOD) e GlutationaPeroxidase (GPx) foram verificadas.
Observamos um aumento da expressão do NF-kb e TNF-α no grupo LPVP, e aumento na expressão da iNOS avaliada por Western blot. A NAC reduziu a expressão de todas as proteínas avaliadas. Observamos um aumento do estresse oxidativo no intestino dos ratos do grupo LPVP com relação aos controles (SO), sendo a NAC eficaz na redução desses valores no grupo LPVP + NAC. Ainda, uma redução na atividade das enzimas SOD e GPx no grupo doente, sendo a NAC capaz de restaurar a atividade das enzimas avaliadas.
Sugerimos a ação anti-inflamatória e antioxidante da NAC no intestino de animais submetidos ao modelo LPVP.
SUCCESSFUL TREATMENT OF INTRACTABLE RECTAL VARICES WITH GELFOAM SLURRY EMBOLISATION AND COILING
2023, European Journal of Case Reports in Internal Medicine
Review of Applied Anatomy, Hemodynamics, and Endovascular Management of Ectopic Varices
2022, Journal of Clinical Interventional Radiology ISVIR

View all citing articles on Scopus

View full text

ANORECTAL VARICES, HAEMORRHOIDS, AND PORTAL HYPERTENSION

Abstract

Lancet

Lancet

Lancet

Lancet

Gastroenterology

The nature of haemorrhoids

Br J Surg

Surgery of the anus rectum and colon